Skip to main content
RxCopaysGet started

Kit for the Preparation of Technetium Tc99m Mertiatide

Generic: Betiatide

Verified·Apr 23, 2026
Manufacturer
Curium
NDC
45567-0655
Route
INTRAVENOUS
ICD-10 indication
R94.4

Affordability Check

How much will you actually pay for Kit for the Preparation of Technetium Tc99m Mertiatide?

In 30 seconds, see every legitimate way to afford Kit for the Preparation of Technetium Tc99m Mertiatide — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Kit for the Preparation of Technetium Tc99m Mertiatide

What is this medication?

The Kit for the Preparation of Technetium Tc99m Mertiatide is a radiopharmaceutical diagnostic agent used in nuclear medicine imaging. Once it is reconstituted with sodium pertechnetate Tc99m, the resulting solution is injected into a patient to allow for detailed visualization of the kidneys and urinary tract. It is primarily used to perform renal scintigraphy, a procedure that helps healthcare professionals examine the anatomy and performance of the renal system in both adult and pediatric patients.

This medication is specifically designed to evaluate kidney function by monitoring how the kidneys filter the blood and produce urine. It is frequently employed to assess renal blood flow, detect potential urinary tract obstructions, and monitor the health of transplanted kidneys. By providing clear images and functional data about the renal organs, the medication assists physicians in diagnosing various conditions, such as chronic kidney disease or structural abnormalities within the urinary system.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

Cost Plus Drug Company

Mark Cuban's transparent-pricing pharmacy — manufacturer cost + 15% markup + $5 dispensing fee. No insurance needed. Search alphabetically for Betiatide.

Browse Cost Plus medications →

GoodRx

Compare local pharmacy prices with GoodRx coupons. Use the price with your insurance or without — whichever is cheaper.

Lookup Kit for the Preparation of Technetium Tc99m Mertiatide →

NeedyMeds

Independent nonprofit directory of patient assistance programs, copay cards, and charity co-pay foundations.

Search for Betiatide →

RxAssist

PAP directory maintained by Volunteers in Health Care at Brown University. Free, no ads.

Search PAPs →

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for Kit for the Preparation of Technetium Tc99m Mertiatide. Official source: DailyMed (NLM) · Label effective Sep 10, 2024

Indications and usage
INDICATIONS AND USAGE Technetium Tc 99m mertiatide is a renal imaging agent for use in the diagnosis of congenital and acquired abnormalities, renal failure, urinary tract obstruction, and calculi in adults and pediatric patients. (See Pediatric Use .) It is a diagnostic aid in providing renal function, split function, renal angiograms, and renogram curves for whole kidney and renal cortex.
Dosage and administration
DOSAGE AND ADMINISTRATION The suggested dose range employed in the average adult patient (70kg) for renal function and imaging studies is 185 MBq (5 mCi) to 370 MBq (10 mCi). In pediatric patients the recommended dose range is 2.6 MBq/kg (70 μCi/kg) to 5.2 MBq/kg (140 μCi/kg) with a minimum dose of 37 MBq (1 mCi). The patient dose should be measured by a suitable radioactivity calibration system immediately prior to administration. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration. Aseptic procedures and a shielded syringe should be employed in withdrawing doses for administration to patients. The user should wear waterproof gloves during the administration procedure.
Contraindications
CONTRAINDICATIONS None known.
Warnings
WARNINGS None known.
Adverse reactions
ADVERSE REACTIONS The following adverse reactions have been reported: nausea, vomiting, wheezing, dyspnea, itching, rash, tachycardia, hypertension, shaking chills, fever, and seizure.
Use in pregnancy
Pregnancy Pregnancy Category C Animal reproduction studies have not been conducted with technetium Tc 99m mertiatide. It is also not known whether this drug can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Technetium Tc 99m mertiatide should be given to a pregnant woman only if clearly needed.

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Prior authorization & coverage

PayerPAStep therapyCopay tier

—

Medicare Part D

———

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.